Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948831 · ClinicalTrials.gov registry record
Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)
A clinical trial of Degenerative Disc Disease Lumbar, sponsored by NuVasive.
- Completed
- Registry status
- 51
- Enrollment target
- 7
- Study locations
NCT00948831 is a study of Degenerative Disc Disease Lumbar that has completed, run by NuVasive. The registered enrollment target is 51 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT00948831, a study of Degenerative Disc Disease Lumbar, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in an ALIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells in conjunction with the allograft bone matrix, so it is hypothesized that the fusion rate with Osteocel Plus will be comparable to published data for autograft. The Osteocel product family has already been used in approximately 15,000 cases worldwide.
Conditions Studied
Interventions
- BIOLOGICAL Osteocel Plus
Study Locations (7)
Indiana
- OrthoIndy, Indiana Orthopedic Hospital - Indianapolis
- Indiana Spine Group, St. Joseph's Hospital - Kokomo
California
- University of California at San Francisco - San Francisco
Minnesota
- Twin Cities Orthopaedics, University of Minnesota Medical Center - Edina
Montana
- Ortho Montana - Billings
Ohio
- Cleveland Clinic - Cleveland
Texas
- Central Texas Spine Institute, Northwest Hills Surgical Hospital - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00948831
The ClinicalTrials.gov registry entry for NCT00948831 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Disc Disease Lumbar appearing as the primary indexed condition, and to 1 intervention - of which Osteocel Plus is the first listed.
NCT00948831 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Indiana, California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00948831 about?
NCT00948831 is a clinical study titled "Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)". This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in an ALIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells in conjunction with the allograft bone matrix...
What is the current status of trial NCT00948831?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2009-04. Estimated completion is 2012-10.
What conditions does trial NCT00948831 study?
This clinical trial studies the following conditions: Degenerative Disc Disease Lumbar.
What interventions are being tested in trial NCT00948831?
The interventions under investigation include: Osteocel Plus (BIOLOGICAL).
Who is sponsoring clinical trial NCT00948831?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00948831 being conducted?
This trial has 7 study locations across California, Indiana, Minnesota, Montana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease Lumbar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.